Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies), Type A, 7
MDDGA7

Contact us
 
Return to database




Prevalence (%) of clinical parameters based on data from 1 references describing 7 individuals







Add new symptom/sign to this disease

Select symptom from list or write it in the box
Pubmed id number as a reference Organ system affected
Number of patients in the reference Percent affected patients (Between 0 and 1, eg. 0.1 = 10%)
Please provide your name and contact information as a reference
Name Institute Phone number Email address


List of symptoms



Symptom/sign Organ system Percent affected Pubmed id Added on(yyyy-mm-dd) Edit/add reference
Cerebellar atrophy nervous 86 % 22522420 2024-05-28
Increased blood CK circulatory 57 % 22522420 2024-05-17
Cataract nervous 57 % 22522420 2024-05-17
Corpus callosum thining nervous 43 % 22522420 2024-05-17
Brainstem hypoplasia nervous 43 % 22522420 2024-05-17
Microphthalmia nervous 43 % 22522420 2024-05-17
Heterotopia nervous 29 % 22522420 2024-05-17
White matter hyperintensities nervous 29 % 22522420 2024-05-17
Pachygyria nervous 29 % 22522420 2024-05-17
Optic nerve atrophy nervous 29 % 22522420 2024-05-17
Muscle atrophy skeletal 29 % 22522420 2024-05-17
Abnormal cornea nervous 14 % 22522420 2024-05-17
Retinal dysplasias nervous 14 % 22522420 2024-05-17
Thinning of cerebral gray matter nervous 14 % 22522420 2024-05-17
Macular degeneration nervous 14 % 22522420 2024-05-17
Brainstem atrophy nervous 14 % 22522420 2024-05-17



List of references:


ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome.
Tobias Willer, Hane Lee, Mark Lommel, Takako Yoshida-Moriguchi, Daniel Beltran Valero de Bernabe, David Venzke, Sebahattin Cirak, Harry Schachter, Jiri Vajsar, Thomas Voit, Francesco Muntoni, Andrea S Loder, William B Dobyns, Thomas L Winder, Sabine Strahl, Katherine D Mathews, Stanley F Nelson, Steven A Moore, Kevin P Campbell,



Nature genetics - May 2012